Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase III,Randomized, Double-blind, Propofol-controlled, Parallel-design, Multi-center Study Evaluating The Efficacy and Safety of HSK3486 for Sedation or Anesthesia in Patients Undergoing Colonoscopy and Gastroscopy

Trial Profile

A Phase III,Randomized, Double-blind, Propofol-controlled, Parallel-design, Multi-center Study Evaluating The Efficacy and Safety of HSK3486 for Sedation or Anesthesia in Patients Undergoing Colonoscopy and Gastroscopy

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 27 Jul 2022

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Cipepofol (Primary) ; Propofol
  • Indications Anaesthesia
  • Focus Registrational; Therapeutic Use
  • Sponsors Sichuan Haisike Pharmaceutical

Most Recent Events

  • 25 Jul 2022 Results assessing compare the deep sedation properties of ciprofol and propofol with a non-inferiority margin of 8% in patients undergoing gastroscopy and colonoscopy, published in the Basic and Clinical Pharmacology and Toxicology.
  • 05 Oct 2020 Primary endpoint (Success of colonoscopy procedure) has been met.
  • 05 Oct 2020 Results presented at the ANESTHESIOLOGY 2020 Annual Meeting of the American Society of Anesthesiologists.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top